Insmed Incorporated (INSM) Financials
INSM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.3 billion | 1.7 billion |
2023-09-30 | 1.3 billion | 1.6 billion |
2023-06-30 | 1.4 billion | 1.6 billion |
2023-03-31 | 1.5 billion | 1.6 billion |
INSM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -133.0 million | 20.0 million |
2023-09-30 | -139.2 million | 20.0 million |
2023-06-30 | -127.7 million | 18.4 million |
2023-03-31 | -149.7 million | 16.4 million |
INSM Net Income
No data available :(
INSM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 780.4 million | - | 48.7 million |
2023-09-30 | 786.0 million | - | 49.7 million |
2023-06-30 | 917.8 million | 1.1 billion | 47.8 million |
2023-03-31 | 998.7 million | 1.1 billion | 52.5 million |
INSM Shares Outstanding
INSM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.2 million | 137.0 million | 89.5 million | - |
2023-09-30 | 2.9 million | 109.1 million | 90.6 million | - |
2023-06-30 | 4.9 million | 197.0 million | 84.4 million | - |
2023-03-31 | 3.4 million | 127.9 million | 79.9 million | - |
INSM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 83.7 million | 18.4 million |
2023-09-30 | 79.1 million | 16.7 million |
2023-06-30 | 77.2 million | 16.6 million |
2023-03-31 | 65.2 million | 13.8 million |
INSM
Price: $25.55
52 week price:
Earnings Per Share: -5.34 USD
P/E Ratio: -5.48
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.3 million
Ebitda: -42.9 millionMarket Capitalization: 4.0 billion